CRISPR-based gene editing technology Casgevy has been approved for treatment of sickle cell disease and beta-thalassaemia in the NHS| Genomics Education Programme
We report on a new test that will help clinicians determine when clopidogrel may harm instead of help The post NICE approves genomic test to prevent secondary strokes appeared first on Genomics Education Programme.| Genomics Education Programme
Gene therapies can take place either 'in vivo' or 'ex vivo'; we compare these two approaches and their importance in gene therapy The post In vivo and ex vivo gene therapies explained appeared first on Genomics Education Programme.| Genomics Education Programme